Eli Lilly LLY
NYSE LLY
$1,437.76 +5.46 (+0.38%)
At close: Nov 11, 2026 · 4:00 PM EST

Eli Lilly (LLY) Shares Outstanding (Diluted) (2009 - 2026)

Updated

Eli Lilly's Weighted Average Shares Outstanding (Diluted) came in at 893.4 million for Q3 2026, down 0.6% from 898.8 million a year earlier and unchanged from the prior quarter.

Analysis

Eli Lilly (LLY) Shares Outstanding (Diluted) (2009 - 2026) Analysis & Trends

For FY2025, Eli Lilly's Weighted Average Shares Outstanding (Diluted) was 899.3 million, down 0.5% from FY2024.

  • Weighted Average Shares Outstanding (Diluted) carries a five-year compound annual growth rate of -0.3% (FY2020 to FY2025).
  • Going back by year, Weighted Average Shares Outstanding (Diluted) was 904.06 million in FY2024 (+0.1%), 903.28 million in FY2023 (-0.1%), 904.62 million in FY2022 (-0.8%) and 911.68 million in FY2021 (-0.1%).
  • The Q3 2026 figure represents the lowest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q1 2009.
  • Year-over-year, Weighted Average Shares Outstanding (Diluted) has declined for seven consecutive quarters, with an average decline of 0.5% over the last eight quarters.
  • The fastest year-over-year change in Weighted Average Shares Outstanding (Diluted) over five years came in Q3 2024 (growth of 0.6%), and the weakest in Q2 2022 (a decline of 0.8%).
  • Business Quant data shows LLY's Weighted Average Shares Outstanding (Diluted) at 893.7 million (Q2 2026), 895.9 million (Q1 2026) and 899.3 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 893.40 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.45 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 1.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.48 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 1.96 Bn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.56 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 546.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.25 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.75 Bn
10 Vertex Pharmaceuticals 138.90 Bn 106.64 Bn 2.91 Bn 255.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 893.40 Mn
Jun 30, 2026 893.70 Mn
Mar 31, 2026 895.90 Mn
Dec 31, 2025 899.30 Mn
Sep 30, 2025 898.80 Mn
Jun 30, 2025 899.80 Mn
Mar 31, 2025 900.60 Mn
Dec 31, 2024 904.06 Mn
Sep 30, 2024 905.00 Mn
Jun 30, 2024 904.20 Mn
Mar 31, 2024 903.80 Mn
Dec 31, 2023 903.28 Mn
Sep 30, 2023 899.80 Mn
Jun 30, 2023 902.70 Mn
Mar 31, 2023 903.30 Mn
Dec 31, 2022 904.62 Mn
Sep 30, 2022 903.80 Mn
Jun 30, 2022 902.90 Mn
Mar 31, 2022 906.40 Mn
Dec 31, 2021 911.68 Mn
API Access

Eli Lilly Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=LLY&period=max&api_key=YOUR_API_KEY